Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: An immunohistochemical study with diagnostic implications

American Journal of Surgical Pathology

Volumn 36, Issue 8, 2012, Pages 1119-1128

  Chen, Benjamin J ^a   Mariño Enríquez, Adrián ^a   Fletcher, Christopher D M ^a   Hornick, Jason L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cellular angiofibroma; cytogenetics; immunohistochemistry; liposarcoma; mammary myofibroblastoma; pleomorphic lipoma; retinoblastoma; soft tissue tumor; spindle cell lipoma

Indexed keywords

RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HEMANGIOFIBROMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOMA; MALE; METABOLISM; MIDDLE AGED; MUSCLE TUMOR; PATHOLOGY; SOFT TISSUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANGIOFIBROMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOMA; MALE; MIDDLE AGED; NEOPLASMS, MUSCLE TISSUE; RETINOBLASTOMA PROTEIN; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863844879     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31825d532d     Document Type: Article

References (44)

1. Dal Cin P, Sciot R, Polito P, et al. Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology. 1997;31:222-225. (Pubitemid 27397914)
2. Fletcher CDM, Akerman M, Dal Cin P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol. 1996;148:623-630. (Pubitemid 26056746)
3. Magro G, Bisceglia M, Michal M, et al. Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinico-pathological analysis of 13 cases in favor of a unifying histogenetic concept. Virchows Arch. 2002;440:249-260. (Pubitemid 34230728)
4. Nucci MR, Granter SR, Fletcher CD. Cellular angiofibroma: a benign neoplasm distinct from angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol. 1997;21:636-644. (Pubitemid 27265750)
5. Iwasa Y, Fletcher CDM. Cellular angiofibroma: clinicopathologic and immunohistochemical analysis of 51 cases. Am J Surg Pathol. 2004;28:1426-1435. (Pubitemid 39425509)
6. Maggiani F, Debiec-Rychter M, Verbeeck G, et al. Extramammary myofibroblastoma is genetically related to spindle cell lipoma. Virchows Arch. 2006;449:244-247.
7. McMenamin ME, Fletcher CD. Mammary-type myofibroblastoma of soft tissue: a tumor closely related to spindle cell lipoma. Am J Surg Pathol. 2001;25:1022-1029. (Pubitemid 32685899)
8. Pauwels P, Sciot R, Croiset F, et al. Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol. 2000;191: 282-285. (Pubitemid 30441252)
9. Flucke U, van Krieken JHJM, Mentzel T. Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Mod Pathol. 2011; 24:82-89.
10. Maggiani F, Debiec-Rychter M, Vanbockrijck M, et al. Cellular angiofibroma: another mesenchymal tumour with 13q14 involvement, suggesting a link with spindle cell lipoma and (extra)mammary myofibroblastoma. Histopathology. 2007;51:410-412. (Pubitemid 47301613)
11. Dahlén A, Debiec-Rychter M, Pedeutour F, et al. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer. 2003;103:616-623. (Pubitemid 36091464)
12. Bartuma H, Nord KH, Macchia G, et al. Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion. Genes Chromosomes Cancer. 2011;50:619-632.
13. Bièche I, Lidereau R. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Mol Carcinog. 2000;29:151-158.
14. Cooney KA, Wetzel JC, Merajver SD, et al. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res. 1996;56: 1142-1145. (Pubitemid 26065413)
15. Latil A, Bièche I, Pesche S, et al. Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer. Hum Pathol. 1999;30:809-815. (Pubitemid 29325788)
16. Zhang X, Xu HJ, Murakami Y, et al. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res. 1994;54:4177-4182. (Pubitemid 24258127)
17. Shaughnessy J, Tian E, Sawyer J, et al. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood. 2000;96:1505-1511. (Pubitemid 30658483)
18. Tamura K, Zhang X, Murakami Y, et al. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer. 1997;74:45-49. (Pubitemid 27157854)
19. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
20. Knudsen ES, Knudsen KE. Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer. 2008;8:714-724.
21. Calo E, Quintero-Estades JA, Danielian PS, et al. Rb regulates fate choice and lineage commitment in vivo. Nature. 2010;466: 1110-1114.
22. Dali-Youcef N, Mataki C, Coste A, et al. Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc Natl Acad Sci USA. 2007;104:10703-10708. (Pubitemid 47185728)
23. Fernandez-Marcos PJ, Auwerx J. pRb, a switch between bone and brown fat. Dev Cell. 2010;19:360-362.
24. Hansen JB, Jørgensen C, Petersen RK, et al. Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci USA. 2004;101:4112-4117. (Pubitemid 38405892)
25. Liegl B, Kepten I, Le C, et al. Heterogeneity of kinase inhibitor resistance mechanisms in GIST. J Pathol. 2008;216:64-74.
26. Mandahl N, Hö glund M, Mertens F, et al. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer. 1994;9:207-215. (Pubitemid 24074738)
27. Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol. 2001;25:809-814. (Pubitemid 32496872)
28. Binh MBN, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340-1347. (Pubitemid 41368770)
29. Italiano A, Bianchini L, Gjernes E, et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res. 2009;15:5696-5703.
30. Maire G, Forus A, Foa C, et al. 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer. 2003;37:389-395. (Pubitemid 36775781)
31. Mertens F, Rydholm A, Brosjö O, et al. Hibernomas are characterized by rearrangements of chromosome bands 11q13-21. Int J Cancer. 1994;58:503-505. (Pubitemid 24268089)
32. Guillou L, Gebhard S, Coindre JM. Lipomatous hemangiopericytoma: a fat-containing variant of solitary fibrous tumor? Clinicopathologic, immunohistochemical, and ultrastructural analysis of a series in favor of a unifying concept. Hum Pathol. 2000;31:1108-1115.
33. Hasegawa T, Matsuno Y, Shimoda T, et al. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum Pathol. 1999;30:1464-1473. (Pubitemid 30032923)
34. Tallini G, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group). Am J Surg Pathol. 1996;20:1047-1055.
35. Nucci MR, Fletcher CD. Vulvovaginal soft tissue tumours: update and review. Histopathology. 2000;36:97-108. (Pubitemid 30113970)
36. Willén H, Akerman M, Dal Cin P, et al. Comparison of chromosomal patterns with clinical features in 165 lipomas: a report of the CHAMP study group. Cancer Genet Cytogenet. 1998;102:46-49. (Pubitemid 28129058)
37. Bartuma H, Hallor KH, Panagopoulos I, et al. Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer. 2007;46:594-606. (Pubitemid 46649574)
38. Chen C, Frierson HF Jr, Haggerty PF, et al. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas. Genomics. 2001;77:135-144. (Pubitemid 32964246)
39. Döhner H, Stilgenbauer S, Fischer K, et al. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia. 1997;11(suppl 2):S19-S24.
40. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002; 99:15524-15529. (Pubitemid 35403967)
41. Bonci D, Coppola V, Musumeci M, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008;14:1271-1277.
42. Fritchie KJ, Carver P, Sun Y, et al. Solitary fibrous tumor: is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? Am J Clin Pathol. 2012;137:963-970.
43. Genuardi M, Klutz M, Devriendt K, et al. Multiple lipomas linked to an RB1 gene mutation in a large pedigree with low penetrance retinoblastoma. Eur J Hum Genet. 2001;9:690-694. (Pubitemid 32923240)
44. Li FP, Abramson DH, Tarone RE, et al. Hereditary retinoblastoma, lipoma, and second primary cancers. J Natl Cancer Inst. 1997;89: 83-84. (Pubitemid 26428082)